LYRA THERAPEUTICS INC (LYRA)

US55234L1052 - Common Stock

4.72  -0.45 (-8.7%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.56M1.36M290.00K0.000.00
Operating Expenses
67.09M56.35M43.90M22.21M16.52M
Research and Development
48.03M38.80M29.69M12.52M12.03M
Selling, General, and Administrative Expenses
19.06M17.56M14.21M9.69M4.49M
Operating Income
-65.53M-54.99M-43.62M-22.21M-16.52M
Interest Income/Expense
4.50M1.04M100.00K80.00K210.00K
Other Income/Expense
N/AN/AN/AN/A0.00
Non Recurring Items
-1.59M-1.32MN/AN/AN/A
Income Before Taxes
-62.62M-55.27M-43.51M-22.13M-16.31M
Income Tax
59.00K10.00KN/AN/AN/A
Net Income
-62.68M-55.28M-43.51M-22.24M-16.31M
EBITDA
-65.25M-53.92M-42.62M-22.11M-16.49M
 
Per Share Data
EPS Diluted Total Ops
-1.26-1.83-3.35-2.59-1.32
Non GAAP EPS
-1.25-1.75-3.35-20.21N/A
 
Statistics
Profit Margin
-4023.11%-4064.71%-15003.45%N/AN/A
Operating Profit Margin
-4205.91%-4043.38%-15041.38%N/AN/A

All data in USD

Charts